Halozyme Therapeutics Inc. Common Stock vs Intercontinental Exchange Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.53 (market cap $12.58B), while Intercontinental Exchange Inc. Common Stock trades at $156.69 (market cap $87.21B). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 6.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.34% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| HALO | ICE | |
|---|---|---|
Market Cap | $12.58B | $87.21B |
Volume | 2,179,278 | 2,029,112 |
Sector | Health | Financials |
52-Week High | $115.22 | $175.10 |
52-Week Low | $61.63 | $122.91 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $14.49B | $105.12B |
Dividend Yield | — | 1.34% |
Trailing returns across standard periods
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →